A new Tel Aviv University (TAU) study reveals that many SARS-CoV-2 variants are likely formed in chronic COVID-19 patients who suffer from immunosuppression. The researchers suggest that a weakened antibody response, particular in the lower airways of these chronic patients, may prevent full recovery from the virus and drive the virus to mutate many times… Read More
A new study from Tel Aviv University (TAU) offers a new and unique treatment for AIDS which may be developed into a vaccine or a one-time treatment for patients with HIV. The study examined the engineering of type B white blood cells in the patient’s body to secrete anti-HIV antibodies in response to the virus…. Read More
Researchers at Tel Aviv University (TAU) have unraveled a mechanism shared by mutations in the genes ADNP and SHANK3, which cause autism, schizophrenia, and other conditions. The researchers also found that an experimental drug previously developed in their lab is effective in lab models for these mutations and may be suitable for treating a range… Read More
A new study from Tel Aviv University (TAU) found that women aged 55 and over who snore are at increased risk for sleep apnea, which can be fatal. The researchers warn that because the phenomenon occurs during sleep, women who suffer from sleep-disordered breathing are not even aware that they are suffering from the problem… Read More
A new study from Tel Aviv University (TAU) enables vaccine developers to determine vaccine safety via smart wearable sensors that measure objective physiological parameters. According to the researchers, most clinical trials testing the safety of new vaccines. including COVID-19 vaccines, rely on participants’ subjective reports, which can lead to biased results. In contrast, objective physiological… Read More
Experts from Tel Aviv University (TAU) have shown that a new combination of common dietary supplements can provide protection against the COVID-19 virus as well as several common winter illnesses. The study was led by Professor Ehud Gazit, Professor Eran Bacharach, and Professor Daniel Segal of the Shmunis School of Biomedicine and Cancer Research at… Read More
Tel Aviv University (TAU) researchers have proven that a drug delivery system based on lipid nanoparticles can utilize RNA to overcome resistance to both chemotherapy and immunotherapy in cancer treatments. The study opens a new path to a personalized and precisely targeted battle against cancer. The study was led by TAU Vice President for R&D… Read More
A new study by Tel Aviv University (TAU), Kaplan Medical Center, and Shamir Medical Center (Assaf Harofeh) found that one in four children (25.3%) who have been discharged from the emergency room after a mild head injury are misdiagnosed and continue to suffer from persistent post-concussion syndrome for many years. This syndrome includes chronic symptoms… Read More